# Huajun Pharmaceutical Group

Huajun Pharmaceutical Group is a Corporate Investor based in Yingkou, China.

## Overview

- **Organization type:** Corporate Investor
- **Headquarters:** Yingkou, China
- **Region:** Asia
- **Address:** Yingkou, Liaoning, China
- **Assets under management:** Undisclosed

## Regulatory record

- **Reports private funds:** No

## About

Huajun Pharmaceutical Group is a corporate investor based in Yingkou, China. It invests in two funds. Its regional focus is Asia.

## Sectors

- Pharmaceuticals
- Real Estate
- Healthcare Services

## People

- Meng Guangbao — Founder and Executive Chairman
- Wu Jiahui — Executive Director, China Huajun Group Limited

## Questions

### Does the group invest only in pharmaceuticals?

No. Despite the pharmaceutical name, the parent Huajun Group holds a diversified asset base that includes commercial real estate in Yingkou, Dalian, and Shanghai, a hot spring resort hotel, and an art collection. Investment activity spans beyond life sciences, though pharmaceutical manufacturing remains the core industrial anchor in the Yingkou industrial park.

### What is the relationship between Huajun Pharmaceutical Group and China Huajun Group Limited?

Huajun Pharmaceutical Group is the healthcare-focused corporate investment entity within China Huajun Group Limited, the parent holding company. Meng Guangbao controls both entities, with governance exercised through his role as Executive Chairman and his spouse's position as an Executive Director of the listed parent.

## Related profiles

- [Huajin Dadao Investment](https://altss.com/profile/huajin-dadao-investment)
- [Huakong Technology Transfer](https://altss.com/profile/huakong-technology-transfer)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/huajun-pharmaceutical-group

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology